| Description | It is a human neutralizing antibody against EBOV glycoprotein (Ebola virus glycoprotein), which is a important surface protein of EBOV. It binds head epitope of EBOV glycoprotein. This product has been determined using Enzyme-linked immunosorbent assay and other applications. |
| Clonality | Monoclonal |
| Host Species | Human |
| Target Species | EBOV |
| Epitope | EBOV glycoprotein head epitope |
| Isotype | Human IgG |
| Expression Species | HEK293F or CHO cell line |
| Conjugation | None |
| Purity | >95%, determined by SDS-PAGE and SEC-HPLC |
| Endotoxin | <1 EU/mg |
| Form | Liquid |
| Purification | Protein A purified |
| Sterility | 0.2 μM filtered |
| Formulation | PBS, pH 7.4 |
| Preservation | No preservatives |
| Stabilizer | No stabilizers |
| Storage | Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics. |
| Application | ELISA |
| ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
| WB | Western Blot Protocol |
| FC | Flow Cytometry Protocol |
| Target | EBOV GP |
| Alternative Name | Ebola virus glycoprotein |
| Research Area | Infectious Disease |
| Related Disease | Severe hemorrhagic fever |
